✦ LIBER ✦

Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer?

✍ Scribed by Vogel, W; Surowy, H

Book ID: 109999272
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 98 KB
Volume: 97
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6603977

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DNA repair capacity as a possible biomar

DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers

✍ Kotsopoulos, J; Chen, Z; Vallis, K A; Poll, A; Ainsworth, P; Narod, S A 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB

Risk of ipsilateral breast cancer in BRC

Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers

✍ Kelly Metcalfe; Henry T. Lynch; Parviz Ghadirian; Nadine Tung; Charmaine Kim-Sin 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 195 KB

Predictors of contralateral breast cance

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

✍ Metcalfe, K; Gershman, S; Lynch, H T; Ghadirian, P; Tung, N; Kim-Sing, C; Olopad 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 345 KB

Body weight and risk of breast cancer in

Body weight and risk of breast cancer in BRCA1/2 mutation carriers

✍ Peggy Manders; Anouk Pijpe; Maartje J. Hooning; Irma Kluijt; Hans F. A. Vasen; N 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 189 KB

Effect of pregnancy as a risk factor for

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers

✍ Carey A. Cullinane; Jan Lubinski; Susan L. Neuhausen; Parviz Ghadirian; Henry T. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

## Abstract Early age at first birth and multiparity have been associated with a decrease in the risk of breast cancer in women in the general population. We examined whether this relationship is also present in women at high risk of breast cancer due to the presence of a mutation in either of the

The efficacy of taxane chemotherapy for

The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers

✍ Mieke Kriege; Agnes Jager; Maartje J. Hooning; Elisabeth Huijskens; Jannet Blom; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 824 KB